September 13-17 | Barcelona, Spain
September 13-17 | Barcelona, Spain
September 13-17 | Barcelona, Spain
September 13-17 | Barcelona, Spain
September 13-17 | Barcelona, Spain
CIRSE meets EAPCI
CIRSE meets EAPCI: Renal denervation
Moderators: R. Morgan (London/GB), F. Mahfoud (Basel/CH)
231.1 / Introduction
R. Morgan (London/GB)
231.2 / Pathophysiology of RDN
M. Sapoval (Paris/FR)
231.3 / The rise, the fall, and the rise of renal denervation
T. Garcia Camarero (Santander/ES)
231.4 / Current devices available/tips and tricks
C. Bent (Bournemouth/GB)
231.5 / RDN and the future of hypertension treatment
F. Mahfoud (Basel/CH)
231.6 / Closing remarks
R. Morgan (London/GB)
EAPCI’s mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions. Since 2006, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) has developed as a privileged space for the interventional community, who are committed to research, scientific advances, education and excellence in medical practice. Due to major developments within the field, such as stenting, TAVI, TEER, among others, their community has grown remarkably.